| abstract |
A compound of Formula (I)n nor nan enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from:n nfurther wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and W are as described herein. n Also disclosed are pharmaceutical compositions containing compounds of Formula (I), and the use of said compounds for treating conditions associated with the activity of p38 kinase. |